Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
lamivudine, Quantity: 300 mg; abacavir sulfate, Quantity: 702.762 mg (Equivalent: abacavir, Qty 600 mg)
Hetero Australia Pty Ltd
Tablet
Excipient Ingredients: sodium starch glycollate; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; sunset yellow FCF; polysorbate 80; macrogol 400
Oral
30's
(S4) Prescription Only Medicine
ABALAMID HETERO 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). ABALAMID HETERO 600/300 is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age.
Visual Identification: Orange modified capsule shaped, biconvex film-coated tablets debossed with 'H' on one side and 'A1' on other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Registered
2022-12-13
ABALAMID HETERO 600/300/06112018/V3 1 ABALAMID HETERO 600/300 TABLETS _abacavir (as sulfate) and lamivudine_ CONSUMER MEDICINE INFORMATION PATIENTS TAKING ABALAMID HETERO 600/300, WHICH CONTAINS ABACAVIR, MAY DEVELOP A HYPERSENSITIVITY REACTION (SERIOUS ALLERGIC REACTION) WHICH CAN BE LIFE-THREATENING IF TREATMENT WITH ABALAMID HETERO 600/300 IS CONTINUED. CONTACT YOUR DOCTOR IMMEDIATELY FOR ADVICE ON WHETHER YOU SHOULD STOP TAKING ABALAMID HETERO 600/300 IF: 1) YOU GET A SKIN RASH OR 2) YOU GET ONE OR MORE SYMPTOMS FROM AT LEAST TWO OF THE FOLLOWING GROUPS: - FEVER - SHORTNESS OF BREATH, SORE THROAT OR COUGH - NAUSEA OR VOMITING OR DIARRHOEA OR ABDOMINAL PAIN - SEVERE TIREDNESS OR ACHINESS OR GENERALLY ILL FEELING IF YOU HAVE HAD A HYPERSENSITIVITY (ALLERGIC) REACTION TO ABALAMID HETERO 600/300 TABLETS, NEVER TAKE ABALAMID HETERO 600/300, OR ANY OTHER MEDICINAL PRODUCT CONTAINING ABACAVIR (KIVEXA, TRIUMEQ, TRIZIVIR & ZIAGEN) AGAIN AS YOU MAY DEVELOP A LIFE THREATENING REACTION WHICH CAN BE FATAL. THERE IS AN ALERT CARD INCLUDED IN THE ABALAMID HETERO 600/300 PACK, TO REMIND YOU AND MEDICAL STAFF ABOUT ABACAVIR HYPERSENSITIVITY. THIS CARD SHOULD BE REMOVED FROM THE PACK AND KEPT WITH YOU AT ALL TIMES. SEE MORE DETAILS UNDER BEFORE YOU TAKE ABALAMID HETERO 600/300. ABALAMID HETERO 600/300/06112018/V3 2 WHAT IS IN THIS LEAFLET? Please read this leaflet carefully before you start ABALAMID HETERO 600/300 tablets. This leaflet answers some common questions about ABALAMID HETERO 600/300 tablets. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist (also known as a chemist). All medicines have benefits and risks. Your doctor has weighed the expected benefits of you taking ABALAMID HETERO 600/300 tablets against the risks this medicine could have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE TABLETS. You may need to read it again. WHAT ABALAMID HETERO 600/300 TABLETS ARE USED FOR A Read the complete document